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Despite the decline of environmental
and occupational lead contamination
in the past few decades, sources of lead
exposure are still found in some
neighborhoods, especially in the more
underprivileged areas (1,2). Moreover,
it has been accepted that there is no
threshold for the deleterious health ef-
fects of lead (3,4). These facts streng-
then the importance of continued
investigation into the effects of lead on
human health.
In the past two decades, increasing
evidence has been gained to support
the fact that chronic lead exposure may
affect bone metabolism (5,6) and
possibly the immune system (7,8). This
evidence makes lead a potential risk
factor for periodontitis – a complex
multifactorial disease that affects bone
– which is initiated by an imbalance of
the host defense system and the
pathogenicity of microorganisms (9).
Lead affects bone metabolism by
interfering with calcium metabolism,
which directly affects bone cells and
bone matrix synthesis (6). Physiologi-
cal mechanisms that control calcium
levels affect the absorption, retention,
and distribution of lead in a similar
manner. As calcium regulates many
cell functions, such as the response to
hormonal and electrical stimuli, the
interference of calcium metabolism by
lead might also affect such cellular
functions (6,10).
The direct effect of lead on osteo-
blasts includes the impairment of bone
matrix synthesis, the process of initi-
ation of mineralization, and the regu-
lation of bone resorption (6).
Impairment of bone matrix is mostly
caused by interference with the colla-
gen and noncollagen protein synthesis
(11,12). Lead also displaces calcium
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Background and Objective: Lead is known to have significant effects on bone
metabolism and the immune system. This study tested the hypothesis that lead
exposure affects periodontitis in adults.
Material and Methods: This study used the data from the Third National Health
and Nutrition Examination Survey (NHANES III, 1988–94). It analyzed data
from 2500 men and 2399 women, 20–56 yr old, who received complete periodontal
examination. Periodontitis was defined as the presence of > 20% of mesial sites
with ‡ 4 mm of attachment loss. Lead exposure was grouped into three categor-
ies: < 3; 3–7; and > 7 lg/dL. Covariates were cotinine levels, poverty ratio, race/
ethnicity, education, bone mineral density, diabetes, calcium intake, dental visit,
and menopause (for women). All analyses were performed separately for men and
women and considering the effect design. Univariate, bivariate, and stratified
analysis was followed by multivariable analysis by estimating prevalence ratios
through poisson regression.
Results: After adjustment for confounders, the prevalence ratios, comparing those
with a lead blood level of >7 lg/dL to those with a lead blood level of <3 lg/dL
was 1.70 (95% confidence interval (CI): 1.02, 2.85) for men and 3.80 (95% CI:
1.66, 8.73) for women.
Conclusion: The lead blood level was positively and statistically associated with
periodontitis for both men and women. Considering the public health importance
of periodontitis and lead exposure, further studies are necessary to confirm this
association.
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ions from synthesized osteocalcin,
which in turn inhibits its binding to
hydroxyapatite, disturbing bone
formation (13,14). In vitro, lead sti-
mulates the proliferation of osteoclast-
like cells from the bone marrow of rats,
and also the production of prosta-
glandin E2 (15).
Clinical evidence of the deleterious
effect of lead exposure on bone meta-
bolism in humans is reduced child
growth (16–18). Development of oste-
openia and osteoporosis (6) has also
been proposed, but the evidence from
human studies is still debatable. Oste-
openia has been reported in rats
exposed to low levels of lead in a dose-
dependent interaction with calcium
intake (19,20).
The effect of lead on the immune
system has been attributed mostly to
downregulation of a cell-mediated
immune response (21). In in vitro and
animal studies, lead exposure has been
associated with imbalances of T-helper
cell (Th1/Th2) activity (22), decreases
in interferon-c, and increases in tumor
necrosis factor (23) and interleukin-12
(24). The effects of lead in humans are
still controversial, mostly because of
lack of control of confounders and
small sample sizes of the majority of
the studies. Among the effects of lead
exposure in humans are the decreased
percentage of monocytes, an increase
in the percentage of CD4+
cells (25,26), and impaired poly-
morphnuclear neutrophil functions
(27,28).
Several of the cellular and immuno-
logic responses to chronic lead exposure
have also been described for periodon-
titis (29–31). We propose that the direct
effect of lead on bone matrix formation
has the potential to interfere with the
progression of periodontitis, because
bone is constantly remodeling and per-
iodontitis is a relatively slowprogressive
disease characterized by periods of
activity and quiescence. A recent study
demonstrated that lead might impair
the bone-healing process (32). Similar
immunologic alterations associated
with lead exposure, such as impaired
chemotaxis and phagocytosis of poly-
morphnuclear neutrophils (29), imbal-
ance of Th1/Th2 cells (31), and an
increase in prostaglandinE2production
(9), have also been reported for perio-
dontitis. In fact, the causal association
between lead exposure and periodonti-
tis has already been proposed (33,34).
However, these studies had some limi-
tations, such as lack of control of con-
founders and inappropriate control
groups. Recently, an analysis of the
Third National Health Examination
Survey (NHANES III) data (35), using
blood lead levels as the outcome vari-
able, proposed that periodontal bone
loss would contribute to the delivery of
lead into the bloodstream. It is possible
that periodontal attachment and bone
loss might contribute to increased lead
blood levels; however, given the epi-
sodic nature of periodontitis, it seems
hardly likely that the association found
was solely the result of periodontal
breakdown tissue. The association
found in that study might, in part, be
attributed to lack of control of
some confounders, such as osteopenia/
osteoporosis (30), menopause (36), and
calcium intake (37). Thus, the objective
of this study was to assess the associa-
tion between lead blood levels and
periodontitis in the United States
population, using data from a repre-
sentative national sample.
Material and methods
Data source and study population
The data source for this study was the
NHANES III, a cross-sectional survey
of a complex, multistage, stratified
clustered sample intended to be repre-
sentative of the civilian noninstitu-
tionalized US population older than
6 mo (38). Oral examinations were
performed in a mobile examination
center by six trained and calibrated
examiners. Clinical evaluation of perio-
dontal tissues was performed in two
diagonally opposite quadrants – one
superior and another inferior – chosen
at random for each individual. Quad-
rants did not include third molars, and
only two sites (mesial-buccal and buc-
cal) per tooth were examined. Detailed
information of examination proce-
dures have been reported previously
(39).
NHANES III had an original sam-
ple size of 39,695 individuals, of whom
33,994 were interviewed. This study
included only individuals from 30 to
55 yr old. Individuals over 55 yr old
were excluded to avoid inclusion of
survivors who predominate in elderly
samples, resulting in an artificial sta-
bilization of average attachment loss
(or prevalence of periodontitis)
according to age in a population. The
cut-off point of 55 yr was based on the
point of stabilization of average
attachment loss (which ranged from 52
to 55 yr old) using a median-smooth-
ing curve plotted for all individuals and
stratified by gender and race/ethnicity.
Only individual Whites, African-
Americans, and Mexican-Americans
with a complete periodontal examina-
tion and information on lead blood
levels were included in this study.
Because of increased bone metabolism
resulting in significant increase in lead
blood levels, pregnant (n ¼ 253) and
breastfeeding (n ¼ 81) women were
excluded from this study. The analyses
thus proceeded with a total of 2399
women and 2500 men.
Outcome variables
The case-definition of periodontitis
was at least 10% of mesial sites with at
least 4 mm of clinical attachment loss
(40). Clinical attachment loss was cal-
culated by subtracting the distance
from the gingival margin to the
cemento–enamel junction from pocket
depth (41). Only the information on
attachment loss from mesial sites was
included, avoiding any influence of
gingival recession from buccal sites,
which may not represent periodontitis.
Exposure variable
Lead exposure was measured as the to-
tal lead blood level (lg/dL). The lead
blood level was categorized into three
levels: < 3 lg/dL; 3–7 lg/dL; and
> 7 lg/dL.For thispopulation, 3lg/dL
represents the 50th percentile and 7 lg/
dL represents approximately the 90th
percentile of the distribution of lead.
Covariates
The following factors were used as
covariates in the regression analysis:
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age, gender, presence of diabetes, cot-
inine blood levels, education, economic
level (poverty), dental caries, tooth
loss, and race/ethnicity (whites, Afri-
can-Americans and Mexican-Ameri-
cans). Diabetes was defined from a
question included in the personal
interview: have you ever been told by a
doctor you had diabetes?. Women
who reported to have had diabetes
only during pregnancy were not con-
sidered as diabetic. Cotinine levels were
used to define tobacco smoking as well
as smoking status (current, former, and
never smokers). Cotinine levels (ng/ml)
were categorized into five levels repre-
senting the 60th, 70th, 80th and 90th
percentile, respectively: < 1.53, 1.54–
63.3, 63.4–202.39, 202.40–305.8, and
>305.9. Education was defined in
three levels as < 12, 12 and >12 yr of
education. Poverty ratio (family in-
come divided by the poverty threshold
for the year in which the family was
interviewed) was categorized into three
levels: £ 1.301; 1.301–3.500; and
>3.500 (38). Serum calcium was cat-
egorized according to the median level.
Levels of bone mineral density
(BMD) were calculated separately for
men and women, based on the stand-
ard deviation of the distribution of
bone mineral density for non-Hispanic
whites from 20 to 29 yr old (42). Very
low levels of BMD (osteoporosis)
refers to more than 2.5 standard devi-
ations below the mean; low levels of
BMD (osteopenia) refers to scores
from 1 to 2.5 standard deviations be-
low the mean; high levels refers to 1
standard deviation below the mean up
to the mean; and very high levels refers
to BMD scores above the mean. The
number of teeth present in the mouth
was also used as covariate in order to
take tooth loss into consideration (41).
Age of the participant’s house was
included in the models in an attempt to
control for factors associated with
current exposure to lead in paint. Time
of construction of the house was
available from NHANES III in three
categories: house built before 1946;
house built between 1946 and 1973;
and house built after 1973. Menopause
status was defined as women not hav-
ing periods in the past 12 mo (exclu-
ding those reporting to be pregnant or
breastfeeding during the past 12 mo).
Current pregnancy information that
was used to exclude individuals was
assessed by the question are you
pregnant now? with the confirmation
of a pregnancy test.
Statistical analysis
The statistical analysis was performed
separately for men and women. This
was because women are submitted to
hormonal influences on bone meta-
bolism during menopause (43), preg-
nancies, and breastfeeding (44). All
analyses took into consideration the
sampling design by using the survey
procedures on the STATA 8.0 statistical
program. Prevalence ratio was used as
measurement of association calculated
through poisson regression (45). Uni-
variate and bivariate analysis was
performed followed by stratified ana-
lysis and modeling. Multivariate
poisson regression models were built
backwards, keeping known con-
founders in the model, even if they
were not significant (alpha ¼ 0.05). As
there was a significant drop in lead
blood levels from the phase I to the
phase II of NHANES III, a variable
identifying the survey phase was
forced into the model. Systematic bias
from examiners was also handled by
considering a variable specific to each
examiner. Some covariates, such as
menopause and osteoporosis, were
forced into the model in an attempt to
control the increased delivery of lead
stored in bones. Also, age of residence
was forced into the model in an at-
tempt to control for recent exposure
to lead. Plausible interactions of the
second order were also tested
(p < 0.10).
Results
The average attachment loss on mesial
tooth sites for women and men were,
respectively, 1.1 mm [standard error
(SE) ¼ 0.05] and 0.93 mm (SE ¼
0.04). Among men, the prevalence of
individuals with at least 10% of their
mesial sites showing attachment loss of
at least 4 mm was 12.3% (SE ¼ 1.0)
and among women the prevalence was
7.2% (SE ¼ 0.61).
Table 1 shows the bivariate analysis
for lead blood levels among women
and men. The unadjusted prevalence
ratio for lead blood level was statisti-
cally associated with periodontitis for
both men and women.
Table 2 shows the adjusted preval-
ence ratio (sequential analysis) as the
confounders are added to the model.
After adjustments for socio-economic
factors, the lead blood level prevalence
ratio showed the highest drop when
cotinine levels were added to the
model. After the addition of cotinine
levels, only small changes were
observed in the adjusted prevalence
ratio for lead blood level, both for men
and for women. We tested the inter-
action between smoking status and
lead blood level and no significant
interactions were found (Table 3). The
interaction between cotinine levels and
lead blood level was also studied, but
no interaction for men was found. The
very small number of women (cells
containing only one individual) with
moderate cotinine levels and high lead
blood levels precluded from testing the
interaction of cotinine and lead blood
level among women. Independent of
smoking status, the prevalence ratio
for high lead blood levels is >1, even
for never smokers to whom the pre-
valence for periodontitis is very small.
Among nonsmoker women, only
1.21% (SE ¼ 0.43) had a lead blood
level of >7 lg/dL and among men
this proportion was 6.2% (SE ¼ 1.4).
Moreover, the trend analysis was sig-
nificant for men (p ¼ 0.0373) and for
women (p ¼ 0.0230). No significant
interactions were observed between
lead blood level and the other covari-
ates evaluated (serum calcium, pov-
erty, race/ethnicity, osteoporosis, and
education).
Discussion
This study showed a significant positive
association between lead and perio-
dontitis for both men and women. The
prevalence ratio, comparing those with
a lead blood level of >7 lg/dL to
those with a lead blood level of
<3 lg/dL, was lower for men (pre-
valence ratio ¼ 1.73, 95% confidence
interval (CI: 1.02, 2.92) than for
Lead exposure and periodontitis 47
Table 1. Characteristics of 30–55-yr-old men (n ¼ 2500) and women (n ¼ 2399) of the US population [data were obtained from the Third
National Health and Nutrition Examination Survey (NHANES III, 1988–94)]
Men Women
n* % SE PR– 95% CI§ n* % SE PR 95% CI
Race/ethnicity
White 873 10.1 1.3 1.00 853 5.3 0.9 1.00
African-American 771 24.2 1.6 2.39 1.78, 3.21 811 12.4 1.3 2.34 1.59, 3.45
Mexican-American 856 12.4 1.2 1.23 0.90, 1.67 735 7.8 1.1 1.47 0.95, 2.26
p-value < 0.0001 < 0.0001
Poverty ratio
> 3.500 699 9.0 1.3 1.00 536 1.9 0.7 1.00
1.301–3.500 716 10.8 1.5 1.18 0.83, 1.70 677 6.6 1.2 3.57 1.61, 7.93
< 1.301 904 19.8 1.8 2.16 1.61, 2.91 1000 13.3 1.8 7.21 3.41, 15.27
p-value < 0.0001 < 0.0001
Education (years)
> 12 915 5.7 0.9 1.00 818 2.3 0.7 1.00
¼ 12 769 15.3 1.8 2.67 1.81, 3.94 851 8.7 1.3 3.72 1.97, 7.02
< 12 750 26.4 2.6 4.61 3.29, 6.46 686 15.0 2.3 6.43 3.37, 12.26
p-value < 0.0001 < 0.0001
Dental visit
Every year/2 yr 1052 7.4 1.0 1.00 1263 2.7 0.6 1.00
Whenever need/never 1333 18.1 1.6 2.46 1.83, 3.32 1084 12.7 1.6 5.08 3.13, 8.25
p-value < 0.0001 < 0.0001
Bone mineral density**
Very high 1102 12.3 1.5 1.00 1230 7.1 1.2 1.00
High 863 11.2 1.7 0.91 0.63, 1.30 646 5.1 1.2 0.72 0.41, 1.27
Low and very low 385 12.9 2.2 1.04 0.68, 1.61 326 7.9 1.8 1.11 0.68, 1.79
p-value 0.7912 < 0.0001
Menopause
No – – – – – 1946 5.1 0.7 1.00
Yes – – – – – 453 12.7 2.4 2.49 1.63, 3.81
p-value < 0.0001
Cotinine level
< 1.53 1321 5.9 0.9 1.00 1600 3.0 0.6 1.00
1.5 3–63.39 300 11.4 2.7 1.92 1.14, 3.23 235 11.3 3.0 3.79 2.03, 7.09
63.40–202.39 285 19.4 3.2 3.27 2.05, 5.21 177 7.7 3.2 2.58 1.07, 6.22
202.40–305.89 247 20.8 4.1 3.50 2.03, 6.04 138 15.5 3.9 5.18 2.46, 10.90
> 305.89 297 25.9 3.9 4.36 2.74, 6.95 201 18.2 4.4 6.11 3.14, 11.90
p-value < 0.0001 < 0.0001
Smoking status
Never 888 4.1 0.7 1.00 1439 3.7 0.6 1.00
Former 707 10.2 1.7 2.50 1.70, 3.66 392 4.6 1.7 1.23 0.57, 2.67
Current 905 22.4 2.6 5.47 3.50, 8.57 568 13.2 2.5 3.54 2.25, 5.57
p-value < 0.0001 < 0.0001
Calcium intake (mg)
‡ 760 1385 9.5 0.9 1.00 924 4.6 1.0 1.00
< 760 1114 15.7 2.0 1.66 1.24, 2.23 1475 7.8 0.9 1.69 1.07, 2.67
p-value 0.0011 0.0247
Diabetes mellitus
No 2402 11.5 1.0 1.00 2296 5.9 0.7 1.00
Yes 98 22.8 6.2 1.98 1.13, 3.48 103 25.3 6.2 4.31 2.64, 7.05
p-value 0.0182 < 0.0001
Lead blood level (lg/dL)
< 3 773 5.5 1.1 1.00 1713 4.1 0.7 1.00
3–7 1268 13.5 1.4 2.45 1.53, 3.93 596 11.5 2.0 2.76 1.67, 4.56
> 7 459 25.6 3.1 4.64 2.91, 7.40 90 39.5 10.5 9.54 5.24, 17.34
p-value < 0.0001 < 0.0001





**Levels of bone mineral density (BMD) were calculated separately for men and women, based on the standard deviation of the distribution of
bone mineral density for 20–29 yr-old non-Hispanic whites. Very low level of BMD (osteoporosis) refers to < 2.5 standard deviations from
the mean; low level of BMD (osteopenia) refers to scores from 1 to 2.5 standard deviations; high levels refers to 1 to lower than the mean; and
very high levels refers to scores above the mean.
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women (prevalence ratio ¼ 3.88, 95%
CI: 1.71, 8.77). However, this differ-
ence may be explained by the different
distribution of lead exposure between
the two groups, which was higher
among men. While the majority of
women were categorized as having a
lead blood level of <3 lg/dL, the
majority of men were exposed to
higher levels (3–7 lg/dL) (Table 1).
Although significant, the association
found in this study needs to be dis-
cussed carefully. We began this study
with the premise that, in the absence of
bias, our results would tend to be an
underestimation of the true associ-
ation, if the association was true. This
premise had the argument that current
lead blood levels occur partially from
recent exposure to lead and partially
from accumulated lead in bones,
resulting in a large variance of lead
exposure. As lead blood levels have
been declining in the USA, it can be
argued that current lead blood levels
among Americans would reflect mostly
recent exposure because the turnover
of lead in bones may take years, or
even decades (2). The decline in lead
blood levels was significant during the
interval between data collection for the
NHANES II survey and the NHANES
III survey (46), but only 13 yr had
elapsed between introduction of the
major regulations to control lead in the
USA [control of lead in gasoline (1973)
and in paint (1977)] to when NHANES
III was conducted (47). It is possible
that the contribution of lead from
bones, as a result of past exposure, was
still a valid assumption in the early
1990s, especially for those people pre-
viously exposed to high levels of lead.
Considering that bone turnover con-
tributes partially to current lead blood
levels, we controlled for factors that
can momentarily increase the delivery
of lead into the bloodstream, such as
menopause and osteopenia/osteopor-
osis, as well as recent exposure to lead,
such as cotinine levels and living in old
houses. Moreover, we excluded woman
who were pregnant and those who
were breast-feeding. If the current lev-
els of lead actually do not reflect past
lead exposure, there are two possible
interpretations for the association
found. As in any cross-sectional study,
the current level of one factor can be
considered as a surrogate of past
exposure. Another possibility is that
the lead blood levels reflect an unap-
preciated variable or residual con-
founder, in particular something
derived from socio-economic level and
smoking. Lead exposure and perio-
dontitis are known to be associated
with socio-economic status and life-
style (48). The standard measurements
of socio-economic status (income levels
and education) have been questioned
as valid measurements of the social
environment and social class (49). It is
possible that with the decline of envi-
ronmental lead in the USA, lead blood
levels has become a better marker for
individuals living in unfavorable social
environments, and those having dele-
terious health habits, such as poor
nutrition, smoking, or living in old
houses in poor neighborhoods. Living
in poor and lower-educated neighbor-
hoods per se has been considered as a
risk indicator of health effect and also
as a predictor of deleterious health
behavior, such as a smoking habit and
Table 2. Sequential analysis showing the effect of confounders on the prevalence ratio (PR)
for periodontitis (‡ 10% of mesial sites with attachment loss ‡ 4 mm) among men (n ¼
2500) and women (n ¼ 2399) of the 30–55 yr US population [data were obtained from the





PR-adj. 95% CI PR-adj. 95% CI
Crude analysis < 3 1.00 1.00
3–7 2.45 1.53, 3.93 2.76 1.67, 4.56
> 7 4.69 2.91, 7.40 9.53 5.24, 17.34
Age + examiner < 3 1.00 1.00
3–7 2.26 1.43, 3.60 2.46 1.46, 4.16
> 7 3.91 2.50, 6.13 7.64 4.59, 12.73
+ NHANES phase + region + < 3 1.00 1.00
house + number of teeth lost + 3–7 1.68 1.08, 2.61 1.77 0.98, 3.19
menopause (only for women)* > 7 2.73 1.72, 4.33 7.02 4.26, 11.56
+ Povert ratio* < 3 1.00 1.00
3–7 1.68 1.05, 2.69 1.52 0.77, 3.01
> 7 2.58 1.63, 4.11 5.01 2.76, 9.07
+ Education* < 3 1.00 1.00
3–7 1.65 1.04, 2.63 1.57 0.79, 3.12
> 7 2.22 1.32, 3.73 4.68 2.49, 8.78
+ Race/ethnicity* < 3 1.00 1.00
3–7 1.63 1.02, 2.61 1.54 0.77, 3.06
> 7 2.16 1.28, 3.66 4.54 2.50, 8.25
+ Cotinine* < 3 1.00 1.00
3–7 1.44 0.89, 2.34 1.14 0.58, 2.23
> 7 1.74 1.02, 2.95 3.74 1.85, 7.55
+ Smoking status* < 3 1.00 1.00
3–7 1,44 0.88, 2.30 1.12 0.56, 2.23
> 7 1.70 1.01, 2.84 3.73 1.83, 7.63
+ Diabetes* < 3 1.00 1.00
3–7 1.42 0.88, 2.31 1.15 0.58, 2.26
> 7 1.72 1.02, 2.90 3.80 1.87, 7.73
+ Calcium intake* < 3 1.00 1.00
3–7 1.38 0.85, 2.23 1.11 0.56, 2.22
> 7 1.68 1.01, 2.80 3.75 1.84, 7.65
+ Dental visit* < 3 1.00 1.00
3–7 1.42 0.88, 2.30 1.10 0.53, 2.26
> 7 1.71 1.01, 2.87 3.50 1.57, 7.81
+ Osteoporosis* < 3 1.00 1.00
3–7 1.37 0.84, 2.23 1.15 0.55, 2.37
> 7 1.70 1.02, 2.85 3.80 1.66, 8.73
*This variable is added to the model containing the all the variables in previous row.
Adjusted prevalence ratio, except for the first row, which shows the crude prevalence ratio.
95% confidence limit.
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lower physical activity (50). It is poss-
ible that oral hygiene and willingness
to access dental treatment, which is
associated with periodontitis (51), may
also be predicted by the neighborhood
environment. Moreover, there is some
evidence that negative life events and
psychosocial stress may be associated
with periodontitis (52). Another possi-
bility is that sustained hardship for
long periods of time may also charac-
terize individuals living in the deprived
and contaminated areas. Elreedy et al.
(1), reported that even after controlling
for traditional individual indicators of
socio-economic status, residence in a
more deprived geographical area was a
modifier of cumulative lead exposure
in bone. Although the mechanism is
not well understood, the contextual
effect of living in a deprived area has
been reported as an independent risk
factor for several diseases (53), inclu-
ding dental caries (54). It is possible
that contamination with lead and other
toxicants may, in part, explain this
contextual effect. There is also some
evidence that lead is highly absorbed in
individuals with poor nutrition, and
who have low calcium and vitamin D
intake, conditions that are more likely
to be observed in poor neighborhoods
(1,55,56). We tested interaction be-
tween calcium intake and iron intake in
our study (data not shown) but neither
calcium nor iron was an effect modi-
fier. However, the lack of evidence of
interaction in a cross-sectional study
does not rule out the possibility of a
past interaction. Therefore, we cannot
rule out that the association found in
this study between lead blood levels
and periodontitis might be a residual
confounder of socio-economic status,
which was represented in this study
only by poverty level and education.
However, some other variables that
could, to a certain extent, reflect other
characteristics of social position were
also used in this study, such as fre-
quency of dental visity and age of the
house. Nevertheless, it is is not known
by how much these variables actually
reduced the influence of residual con-
founders.
Residual confounder from smoking
is another potential threat to the
validity of any study of risk factors for
periodontitis (57). Associations of
periodontitis with systemic diseases
have been attributed mostly to residual
confounding from smoking (57).
Despite theoretical explanations for
the association found in this study, it is
important to point out that the
association between lead blood levels
and attachment loss was moderate and
very stable, independently of con-
founders.
A major limitation of this study is its
design, facing the constant decline of
lead exposure in the USA and its
unequal decline associated with socio-
economic position. Moreover, the low
levels of lead, and the consequently
relatively small sample size of people
with high exposure, preclude us from
testing interactions that could be
important in understanding the
association. None of the interactions
tested were statistically significant.
In spite of some weaknesses, the
strength of this study is that NHANES
III is a complex random sample rep-
resentative of the US population, and
thus selection bias common to occu-
pational studies is not expected to be
responsible for our results.
By contrast with a recent analysis of
NHANES III (35), in which attach-
ment loss was evaluated as a possible
source of lead delivered into the
bloodstream, we failed to observe an
interaction between smoking and lead
blood levels. One possible reason is that
we excluded individuals over 56 yr old
to avoid a survivorship influence. In
spite of better oral health, the inclusion
of individuals older than 55 yr old
increases the proportion of individu-
als with possible confounders such as
osteopenia, osteoporosis, and meno-
pause. These conditions are associated
with increased bone turnover, resulting
in an increase of lead blood levels
(36,43), and are also associated with
periodontitis. In that study there were
no adjustments for such conditions, or
even adjustment for the number of
teeth present in the mouth (57).
Table 3. Interaction between smoking status and lead blood levels, with and without coti-





PR-adj. 95% CI PR 95% CI
Interaction with cotinine
level in the model
Never smokers < 3 1.00 1.00
3–7 1.19 0.51, 2.77 1.01 0.37, 2.81
> 7 1.25 0.43, 3.61 2.59 0.85, 7.90
Past smokers < 3 1.44 0.59, 3.53 0.49 0.10, 2.33
3–7 1.83 0.77, 4.36 1.67 0.55, 5.01
> 7 3.17 1.24, 8.09 9.04 2.41, 33.94
Current smokers < 3 1.79 0.70, 4.56 0.69 0.18, 2.57
3–7 2.72 1.08, 6.83 0.71 0.14, 3.52
> 7 3.07 1.22, 7.71 1.79 0.38, 8.41
p-value* 0.8253 0.3514
Interaction without cotinine
level in the model
Never smokers < 3 1.00 1.00
3–7 1.25 0.55, 2.83 1.04 0.40, 2.69
> 7 1.36 0.48, 3.88 2.49 0.70, 8.84
Past smokers < 3 1.69 0.71, 4.03 0.51 0.09, 3.01
3–7 1.92 0.83, 4.44 2.16 0.83, 5.61
> 7 3.27 1.29, 8.29 8.28 2.16, 31.75
Current smokers < 3 2.29 0.94, 5.61 2.65 1.28, 5.46
3–7 3.57 1.61, 7.95 3.02 1.22, 7.51
> 7 4.10 1.77, 9.51 7.18 3.12, 16.55
p-value* 0.8360 0.5243
*p-value for the interaction between smoking status and lead blood level.
Adjusted prevalence ratio.
95% confidence limit.
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This study showed a positive statis-
tically significant association between
PbB and periodontitis after adjusting
for major known risk factors. In spite
of relatively low levels of exposure to
lead among the US population, the
persistence of lead contamination
among areas of underprivileged seg-
ments of society, as well as a higher
prevalence of periodontitis among the
poorest, further studies are necessary
to confirm this association. Studies
using cumulative measures of lead, as
well as studies using populations or
occupational groups exposed to high
levels of lead, may give us a more
complete picture of the statistical
association found in this study.
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